By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Proteros Biostructures said today that it has agreed to investigate potential small molecule lead compounds for Johnson & Johnson Pharmaceutical Research and Development (J&JPRD).
Registering provides access to this and other free content.
Already have an account?Login Now.
By analyzing tweets, Canadian researchers examine the public's view of gene patenting.
In Science this week: issues in reproducibility, circulating DNA predicts breast cancer relapse, and more.
Because of an autoimmune disorder, a man has been shedding live polioviruses for 28 years, according to an analysis appearing in PLOS Pathogens.
Being in a long-term collaboration can increase researchers' citation rates by 17 percent, a recent analysis says.